Journal of Vascular Surgery

Syndicate content
Journal of Vascular Surgery RSS feed.
Updated: 6 hours 3 min ago

Information for readers

31 October 2018 - 11:00pm
Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 633 N. St. Clair, 22nd Floor, Chicago, IL 60611; telephone: 603-523-2222; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors should consult this document before submitting manuscripts to this Journal.

Information for authors

31 October 2018 - 11:00pm
Complete information for authors and editorial policies are available in the January and July issues, at our Web site www.jvascsurg.org, or at our Editorial Manager Web site at jvs.editorialmanager.com. An abbreviated checklist for manuscript submission follows. Manuscripts that are accepted for publication become the property of the Journal of Vascular Surgery®, which is copyrighted by the Society for Vascular Surgery®. They may not be published or reproduced in whole or in part without the written permission of the author(s) and the Journal.

Contents

31 October 2018 - 11:00pm

Editorial Board

31 October 2018 - 11:00pm

LEO 8. Diabetic Foot Limb Salvage: A Series of 809 Attempts and Predictors for Endovascular Limb Salvage Failure

31 October 2018 - 11:00pm
The objective of this study was to review patients’ characteristics and outcomes of inpatient diabetic foot limb salvage and to identify risk factors predicting endovascular limb salvage failure.

LEO 7. Safety and Effectiveness of the Novel Temren Atherectomy System Combined Use With Extender Drug-Eluting Balloon in Lower Extremity Arteries

31 October 2018 - 11:00pm
The objective of this study was to evaluate the novel Temren atherectomy system and Extender drug-eluting balloon (RD Global-Invamed, Ankara, Turkey) as percutaneous treatment of de novo and restenotic infrainguinal arterial lesions.

LEO 6. Ferumoxytol-Enhanced Magnetic Resonance Angiography—Clinical Feasibility and Optimal Dosing

31 October 2018 - 11:00pm
Traditional contrast media are problematic in advanced chronic kidney disease. Ultrasmall superparamagnetic particles of iron oxide (ferumoxytol) are safe in chronic kidney disease and have been used for imaging in other settings. We tested the feasibility of ferumoxytol-enhanced magnetic resonance angiography (FeMRA) in patients with renal failure and performed a dose-finding study.

Introduction

31 October 2018 - 11:00pm
The Associate Faculty program of the VEITHsymposium was the first forum ever created to motivate young and upcoming vascular specialists as well as more experienced clinicians to present their ongoing clinical and basic science research. This effort turned out to be very successful and it was soon replicated by other large symposia.

LEO 5. The Impact of a Nationwide Network of Community-Based Supervised Exercise Therapy on the Management of Intermittent Claudication in The Netherlands

31 October 2018 - 11:00pm
Contemporary guidelines recommend supervised exercise therapy (SET) as initial treatment in intermittent claudication (IC). Unfortunately, limited access to adequate SET programs impedes referral, thereby exposing patients to potentially unnecessary vascular interventions. With Medicare covering SET for its beneficiaries as of 2017, an important barrier to widespread adoption has been overcome. Next, health care providers are tasked with making uniform, high-quality SET accessible for all U.S. IC patients.

LEO 4. Aspiration Thrombectomy for Acute Limb Ischemia: A Single-Center Experience

31 October 2018 - 11:00pm
The objective of this study was to report our single-center experience with percutaneous aspiration thrombectomy (PAT) as a first-line treatment of acute lower limb ischemia (ALI).

LEO 2. Arterial Preparation Improves Outcomes of Drug-Coated Balloon Angioplasty

31 October 2018 - 11:00pm
Angioplasty without arterial preparation can lead to complications including large, uncontrolled dissections. Arterial preparation can mitigate these risks, providing a better lumen patency, limiting the use of stents, avoiding excess wall stretch from high-pressure balloons, and decreasing the need for stents.

LEO 1. Total Endovascular Management of Aortoiliac Occlusive Disease

31 October 2018 - 11:00pm
We aimed to compare the effectiveness of total endovascular repair of aortoiliac occlusive disease with the “gold standard” of aortobifemoral bypass.

MSC 2. What Do Patients Want to Know About Their Surgeon? Stakeholder Views of Surgeon-Specific Mortality Data

31 October 2018 - 11:00pm
Surgeon-specific mortality data (SSMD) are used to enhance transparency, to drive quality improvement, and to facilitate patients’ choice. The use of SSMD is controversial, but patients’ views on such data are largely unknown. The aim of this study was therefore to establish the views of patients and to identify their priorities for outcome reporting.

MSC 1. Aviation Safety—Five Human-Factors Lessons for Vascular Surgeons

31 October 2018 - 11:00pm
Flying commercially is far safer than undergoing surgery. Nevertheless, pilots and vascular surgeons face similar types of technical and environmental challenges. Differences in outcomes may be attributed to the use of human-factors science in the aviation industry. The study aimed to identify methods of improving patients’ safety in vascular surgery based on the expertise of senior airline pilots.

LUE 2. Midterm Clinical Outcome of Minimally Invasive Vein-Restoring Treatment Method for Chronic Venous Insufficiency

31 October 2018 - 11:00pm
The conventional therapeutic option for varicose veins associated with significant saphenofemoral incompetence is high ligation, sclerotherapy, or thermal ablation, which includes a disadvantage that the vein is no longer available as a graft for future cardiovascular surgery. Internal compression therapy (RD Global-Invamed, Ankara, Turkey) is a new, minimally invasive procedure to restore venous valve competence by reducing the vein’s circumference. The procedure is also called percutaneous valvuloplasty.

LUE 1. A Comparative Analysis of the Results of Cyanoacrylate Ablation and Radiofrequency Ablation in the Treatment of Venous Insufficiency

31 October 2018 - 11:00pm
Varicose vein treatment has been directed toward less invasive yet lasting techniques. This study was designed to compare the effectiveness of cyanoacrylate ablation (CAA) with that of radiofrequency ablation (RFA).

HDA 2. Use of Covered Stents in Central Vein Stenosis After Vascular Accesses

31 October 2018 - 11:00pm
Percutaneous transluminal angioplasty (PTA) in central vein stenosis represents the first therapeutic option, although high rates of restenosis are present. The aim of the study was to present our experience in using nitinol-polytetrafluoroethylene covered stents in the treatment of central vein stenosis.

HDA 1. Novel Use of the ClariVein Catheter for Pharmacomechanical Thrombolysis of Thrombosed Arteriovenous Grafts

31 October 2018 - 11:00pm
The aim of this prospectively collected case series was to demonstrate a novel technique of using the ClariVein (Vascular Insights, Quincy, Mass) catheter for pharmacomechanical thrombolysis of thrombosed hemodialysis grafts.

CAD 6. Clinical Results and Experimental Data of a MicroNet-Covered Carotid Stent (CGuard)

31 October 2018 - 11:00pm
This was an assessment of the clinical implantation procedure and in vitro investigation of the mechanical properties of the novel MicroNet-covered stent for the carotid artery.

CAD 5. Risk Factors for Stroke After Carotid Surgical Interventions

31 October 2018 - 11:00pm
We aimed to assess stroke rates after carotid revascularization surgery and to identify factors influencing stroke. The primary end point was the incidence of 30-day periprocedural major stroke and the time to stroke postoperatively. Secondary end points included minor stroke, myocardial infarction, and overall survival.